NR1 /NMDAR1 C-term

ANTIBODY monoclonal manufacturer Cat# 05-432<br />Reference: <br /><a href="/papers/genetic-reduction-striatal-enriched-tyrosine-phosphatase-step-reverses-cognitive-and-cellular" target="_new">Zhang Y, 2010</a> Immunogen

Drebrin

ANTIBODY polyclonal manufacturer Cat.# D3816<br />Reference: <br /><a href="/papers/dendritic-function-tau-mediates-amyloid-beta-toxicity-alzheimers-disease-mouse-models" target="_new">Ittner, 2010</a> immunogen = synthe

Lindsay Reese

University Of Vermont
Burlington, United States

San Diego: Aβ Oligomers Seen, With ApoE, at Synapses of Human Brain

CONFERENCE COVERAGE 2010-12-06 Conference Coverage Apolipoprotein E is the strongest genetic risk factor for late-onset Alzheimer’s disease, accounting for more than 95 percent of cases. But despite decades of research, it is still not clear how it ties in with AD etiology. At the Soci

Fyn (15)

ANTIBODY monoclonal 15 manufacturer sc-434<br />Reference: <br /><a href="/papers/dendritic-function-tau-mediates-amyloid-beta-toxicity-alzheimers-disease-mouse-models" target="_new">Ittner, 2010</a> epitope mapping betw

San Diego: A New Tack on Insulin-Based Therapies?

CONFERENCE COVERAGE 2010-12-05 Conference Coverage Shoring up insulin responses is a tried-and-true strategy for helping people manage type 2 diabetes (T2D), but could it also prevent or delay Alzheimer’s disease? Strong epidemiological evidence suggests diabetes is a risk factor for A

PAPER Jin CH, Wu SW, Zhou P, Liu QF, Lu XB, Shi LD, Cai Y

[Effect of aluminum on Ca²+ concentration and expression of phospholipase C and NMDA receptor α genes in hippocampus of weaning rats as well as their neural behavior through subchronic exposure].

Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi. 2010 Sep;28(9):648-51. PubMed: 21126475

PAPER Noto Y, Shibuya K, Sato Y, Kanai K, Misawa S, Sawai S, Mori M, Uchiyama T, Isose S, Nasu S, Sekiguchi Y, Fujimaki Y, Kasai T, Tokuda T, Nakagawa M, Kuwabara S

Elevated CSF TDP-43 levels in amyotrophic lateral sclerosis: specificity, sensitivity, and a possible prognostic value.

Amyotroph Lateral Scler. 2011 Mar;12(2):140-3. PubMed: 21126161

PAPER Hu JF, Song XY, Chu SF, Chen J, Ji HJ, Chen XY, Yuan YH, Han N, Zhang JT, Chen NH

Inhibitory effect of ginsenoside Rg1 on lipopolysaccharide-induced microglial activation in mice.

Brain Res. 2011 Feb 16;1374:8-14. PubMed: 21126513

PAPER Shimizu T, Honda M, Ohashi T, Tsujino M, Nagaoka U, Kawata A, Watabe K, Matsubara S, Hayashi H

Hyperosmolar hyperglycemic state in advanced amyotrophic lateral sclerosis.

Amyotroph Lateral Scler. 2011 Sep;12(5):379-81. PubMed: 21126160

PAPER Smith JA, Das A, Butler JT, Ray SK, Banik NL

Estrogen or estrogen receptor agonist inhibits lipopolysaccharide induced microglial activation and death.

Neurochem Res. 2011 Sep;36(9):1587-93. PubMed: 21127968

PAPER Das A, McDowell M, O'Dell CM, Busch ME, Smith JA, Ray SK, Banik NL

Post-treatment with voltage-gated Na(+) channel blocker attenuates kainic acid-induced apoptosis in rat primary hippocampal neurons.

Neurochem Res. 2010 Dec;35(12):2175-83. PubMed: 21127971

PAPER Gusdon AM, Chu CT

To eat or not to eat: neuronal metabolism, mitophagy, and Parkinson's disease.

Antioxid Redox Signal. 2011 May 15;14(10):1979-87. PubMed: 21126205

PAPER Dorst J, Kühnlein P, Hendrich C, Kassubek J, Sperfeld AD, Ludolph AC

Patients with elevated triglyceride and cholesterol serum levels have a prolonged survival in amyotrophic lateral sclerosis.

J Neurol. 2011 Apr;258(4):613-7. PubMed: 21128082

PAPER Qureshi HY, Paudel HK

Parkinsonian neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) and alpha-synuclein mutations promote Tau protein phosphorylation at Ser262 and destabilize microtubule cytoskeleton in vitro.

J Biol Chem. 2011 Feb 18;286(7):5055-68. PubMed: 21127069